On November 20, 2023, in connection with the Dissolution, Evelo Biosciences, Inc. announced Marella Thorell ceased serving as the Company?s Chief Financial Officer. Ms. Thorell will cease their employment with the Company effective on December 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0495 USD | +8.32% | 0.00% | -19.51% |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
1st Jan change | Capi. | |
---|---|---|
-19.51% | 940K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- EVLO Stock
- News Evelo Biosciences, Inc.
- Evelo Biosciences, Inc. Announces Marella Thorell Cease as Chief Financial Officer, Effective on December 1, 2023